Asset
Amoxicillin
Revenue
No revenue reported in loaded filings.
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04753437 | phase1 | completed | 2021-04-06 | 2021-09-27 | Takeda | A Study of Vonoprazan in Adults With Helicobacter Pylori |
| NCT04198363 | phase3 | completed | 2020-04-30 | 2021-11-01 | Takeda | A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection |
| NCT01442688 | phase1 | completed | 2011-10-07 | 2011-11-20 | Shire | Amoxicillin Drug Interaction Study With MMX® Mesalazine/Mesalamine |
| NCT01505127 | phase3 | completed | 2012-01-01 | 2013-06-01 | Takeda | Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori |
| NCT02892409 | phase1 | completed | 2016-09-05 | 2017-04-17 | Takeda | TAK-438 Bismuth Drug Interaction Study |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 050757 | NDA | TAKEDA PHARMACEUTICALS USA INC |
Marketed products (1)
- PREVPAC (COPACKAGED)